Notice Title

Consent to the Distribution of New Medicines

Publication Date
17 Apr 2025

Tags

Medicines Act Consent to the distribution of new medicines

Notice Number

2025-go2096
Title
View PDF
File Type and Size
PDF (40 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Daktarin Pressurised Spray
Active Ingredient: Miconazole nitrate 0.16%w/w equivalent to miconazole nitrate dry powder 2%w/w
Dosage Form: Topical spray powder
New Zealand Sponsor: JNTL Consumer Health (New Zealand) Limited
Manufacturer: Ensign Laboratories Pty Limited, Melbourne, Australia
   
Product: Demazin 12 Hour Nasal Decongestant Spray
Active Ingredient: Oxymetazoline hydrochloride 0.5mg/mL
Dosage Form: Nasal spray solution
New Zealand Sponsor: Noumed Pharmaceuticals Limited
Manufacturer: Probiotec Pharma Pty Limited, Melbourne, Australia
   
Product: Levosert
Active Ingredient: Levonorgestrel 52mg
Dosage Form: Intrauterine contraceptive device
New Zealand Sponsor: AbbVie Limited
Manufacturer: Odyssea Pharma S.A., Grace-Hollogne, Belgium
   
Product: Sleep Safe Balance 1.5% glucose, 1.25mmol/L Ca
Active Ingredients: Calcium chloride dihydrate 0.1838g/L
Glucose monohydrate 16.5g/L equivalent to glucose anhydrous 15g/L
Magnesium chloride hexahydrate 0.1017g/L
Sodium chloride 5.64g/L
Sodium lactate 3.925g/L
Dosage Form: Dialysis solution
New Zealand Sponsor: Maxx Pharma NZ Limited
Manufacturers: Fresenius Medical Care Deutschland GmbH, St Wendel, Germany
Fresenius Medical Care Japan KK, Buzen-shi, Japan
Note: Applications were received 10 November 2021 and 14 February 2023
   
Product: Sleep Safe Balance 2.3% glucose, 1.25mmol/L Ca
Active Ingredients: Calcium chloride dihydrate 0.1838g/L
Glucose monohydrate 25g/L equivalent to glucose anhydrous 22.73g/L
Magnesium chloride hexahydrate 0.1017g/L
Sodium chloride 5.64g/L
Sodium lactate 3.925g/L
Dosage Form: Dialysis solution
New Zealand Sponsor: Maxx Pharma NZ Limited
Manufacturers: Fresenius Medical Care Deutschland GmbH, St Wendel, Germany
Fresenius Medical Care Japan KK, Buzen-shi, Japan
Note: Applications were received 10 November 2021 and 14 February 2023
   
Product: Sleep Safe Balance 4.25% glucose, 1.25mmol/L Ca
Active Ingredients: Calcium chloride dihydrate 0.1838g/L
Glucose monohydrate 46.75g/L
Magnesium chloride hexahydrate 0.1017g/L
Sodium chloride 5.64g/L
Sodium lactate 3.925g/L
Dosage Form: Dialysis solution
New Zealand Sponsor: Maxx Pharma NZ Limited
Manufacturers: Fresenius Medical Care Deutschland GmbH, St Wendel, Germany
Fresenius Medical Care Japan KK, Buzen-shi, Japan
Note: Applications were received 10 November 2021 and 14 February 2023
   
Product: Stay Safe Balance 1.5% glucose, 1.25mmol/L Ca
Active Ingredients: Calcium chloride dihydrate 0.1838g/L
Glucose monohydrate 16.5g/L equivalent to glucose anhydrous 15g/L
Magnesium chloride hexahydrate 0.1017g/L
Sodium chloride 5.64g/L
Sodium lactate 3.925g/L
Dosage Form: Dialysis solution
New Zealand Sponsor: Maxx Pharma NZ Limited
Manufacturers: Fresenius Medical Care Deutschland GmbH, St Wendel, Germany
Fresenius Medical Care Japan KK, Buzen-shi, Japan
Note: Applications were received 10 November 2021 and 14 February 2023
   
Product: Stay Safe Balance 2.3% glucose, 1.25mmol/L Ca
Active Ingredients: Calcium chloride dihydrate 0.1838g/L
Glucose monohydrate 25g/L equivalent to glucose anhydrous 22.73g/L
Magnesium chloride hexahydrate 0.1017g/L
Sodium chloride 5.64g/L
Sodium lactate 3.925g/L
Dosage Form: Dialysis solution
New Zealand Sponsor: Maxx Pharma NZ Limited
Manufacturers: Fresenius Medical Care Deutschland GmbH, St Wendel, Germany
Fresenius Medical Care Japan KK, Buzen-shi, Japan
Note: Applications were received 10 November 2021 and 14 February 2023
   
Product: Stay Safe Balance 4.25% glucose, 1.25mmol/L Ca
Active Ingredients: Calcium chloride dihydrate 0.1838g/L
Glucose monohydrate 46.75g/L equivalent to glucose anhydrous 42.5g/L
Magnesium chloride hexahydrate 0.1017g/L
Sodium chloride 5.64g/L
Sodium lactate 3.925g/L
Dosage Form: Dialysis solution
New Zealand Sponsor: Maxx Pharma NZ Limited
Manufacturers: Fresenius Medical Care Deutschland GmbH, St Wendel, Germany
Fresenius Medical Care Japan KK, Buzen-shi, Japan
Note: Applications were received 10 November 2021 and 14 February 2023


Dated this 14th day of April 2025.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).